Developments in transcatheter aortic bioprosthesis durability

References

• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–1715.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–1705.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Petronio AS, Ettori F, et al. 5-year outcomes after transcatheter aortic valve implantation with coreValve prosthesis. JACC Cardiovasc Interv. 2015;8(8):1084–1091.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–2484.
   PubMed Web of Science ®Google Scholar
• Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485–2491.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gabella T, Voisine P, Puri R, et al. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol. 2017;70(8):1013–1028.
   PubMed Web of Science ®Google Scholar
• Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;38(45):3382–3390.
   PubMed Web of Science ®Google Scholar
• Søndergaard L, Ihlemann N, Capodanno D, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73(5):546–553.
   PubMed Web of Science ®Google Scholar
• Dvir D, Bourguignon T, Otto CM, et al. Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation. 2018;137(4):388–399.
   PubMed Web of Science ®Google Scholar
• Sénage T, Le Tourneau T, Foucher Y, et al. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients. Circulation. 2014;130(23):2012–2020.
   PubMed Web of Science ®Google Scholar
• Mahjoub H, Mathieu P, Sénéchal M, et al. ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration. J Am Coll Cardiol. 2013;61(7):752–761.
   PubMed Web of Science ®Google Scholar
• Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32(2):205–217.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–1454.
   PubMed Web of Science ®Google Scholar
• Dvir D, Webb J, Brecker S, et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation. 2012;126(19):2335–2344.
   PubMed Web of Science ®Google Scholar
• Bourguignon T, El Khoury R, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 60 or younger. Ann Thorac Surg. 2015;100(3):853–859.
   PubMed Web of Science ®Google Scholar
• Bourguignon T, Bouquiaux-Stablo AL, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position. Ann Thorac Surg. 2015;99(3):831–837.
   PubMed Web of Science ®Google Scholar
• Johnston DR, Soltesz EG, Vakil N, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99(4):1239–1247.
   PubMed Web of Science ®Google Scholar
• Forcillo J, El Hamamsy I, Stevens LM, et al. The perimount valve in the aortic position: twenty-year experience with patients under 60 years old. Ann Thorac Surg. 2014;97(5):1526–1532.
   PubMed Web of Science ®Google Scholar
• Hickey GL, Bridgewater B, Grant SW, et al. National registry data and record linkage to inform postmarket surveillance of prosthetic aortic valve models over 15 years. JAMA Intern Med. 2017;177(1):79–86.
   PubMed Web of Science ®Google Scholar
• Yankah CA, Pasic M, Musci M, et al. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg. 2008;136(3):688–696.
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J, Webb JG, Cheung A, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60(19):1864–1875.
   PubMed Web of Science ®Google Scholar
• Chakravarty T, Søndergaard L, Friedman J, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389(10087):2383–2392.
   PubMed Web of Science ®Google Scholar
• Toggweiler S, Humphries KH, Lee M, et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;61(4):413–419.
   PubMed Web of Science ®Google Scholar
• Gerckens U, Tamburino C, Bleiziffer S, et al. Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. Eur Heart J. 2017;38(36):2729–2738.
   PubMed Web of Science ®Google Scholar
• Didier R, Eltchaninoff H, Donzeau-Gouge P, et al. Five-year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients. Circulation. 2018;138(23):2597–2607.
   PubMed Web of Science ®Google Scholar
• Pollari F, Fischlein T, Pfeiffer S. Comparison of surgical and transcatheter aortic valve prostheses: size matters. J Am Coll Cardiol. 2019;73(21):2784.
   PubMed Web of Science ®Google Scholar
• Dvir. First look at long-term durability of transcatheter heart valves: assessment of valve function up to 10-years after implantation. Euro PCR. Paris; 2016.
   Google Scholar
• Durand E, Sokoloff A, Urena-Alcazar M, et al. Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using the new european definition. Circ Cardiovasc Interv. 2019;12(4):e007597.
   PubMed Web of Science ®Google Scholar
• Eltchaninoff H, Durand E, Avinée G, et al. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition. EuroIntervention. 2018;14(3):e264–e271.
   PubMed Web of Science ®Google Scholar
• Holy EW, Kebernik J, Abdelghani M, et al. Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure. EuroIntervention. 2018;14(4):e390–e396.
   PubMed Web of Science ®Google Scholar
• Deutsch MA, Erlebach M, Burri M, et al. Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices. EuroIntervention. 2018;14(1):41–49.
   PubMed Web of Science ®Google Scholar
• Panico RA, Giannini C, De Carlo M, et al. Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years. EuroIntervention. 2019;14(16):1639–1647.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Costa G, Zappulla P, et al. Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement. J Am Heart Assoc. 2018;7(15):e008440.
   PubMed Web of Science ®Google Scholar
• Blackman DJ, Saraf S, MacCarthy PA, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol. 2019;73(5):537–545.
   PubMed Web of Science ®Google Scholar
• Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018;39(8):687–695.
   PubMed Web of Science ®Google Scholar
• Pibarot P, Simonato M, Barbanti M, et al. Impact of pre-existing prosthesis-patient mismatch on survival following aortic valve-in-valve procedures. JACC Cardiovasc Interv. 2018;11(2):133–141.
   PubMed Web of Science ®Google Scholar
• Salaun E, Zenses AS, Clavel MA, et al. Valve-in-valve procedure in failed transcatheter aortic valves. JACC Cardiovasc Imaging. 2019;12(1):198–202.
   PubMed Web of Science ®Google Scholar
• Schmidt T, Frerker C, Alessandrini H, et al. Redo TAVI: initial experience at two German centres. EuroIntervention. 2016;12(7):875–882.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Webb JG, Tamburino C, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure. Circ Cardiovasc Interv. 2016;9(9).
   Web of Science ®Google Scholar
• Tchetche D, de Biase C, van Gils L, et al. Bicuspid aortic valve anatomy and relationship with devices: the BAVARD multicenter registry. Circ Cardiovasc Interv. 2019;12(1):e007107.
   PubMed Web of Science ®Google Scholar
• Roberts WC, Janning KG, Ko JM, et al. Frequency of congenitally bicuspid aortic valves in patients >/=80 years of age undergoing aortic valve replacement for aortic stenosis (with or without aortic regurgitation) and implications for transcatheter aortic valve implantation. Am J Cardiol. 2012;109(11):1632–1636.
   PubMed Web of Science ®Google Scholar